Detalhe da pesquisa
1.
Initiation of quarterly palmitate paliperidone in French clinical practice: Results from the observational, cross-sectional OPTIMUS study.
Pharmacoepidemiol Drug Saf
; 31(3): 334-342, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897888
2.
Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme.
Int J Psychiatry Clin Pract
; 26(4): 352-362, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35174754
3.
Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France.
J Clin Psychopharmacol
; 38(1): 19-26, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29232310
4.
Predictive factors of functional remission in patients with early to mid-stage schizophrenia treated by long acting antipsychotics and the specific role of clinical remission.
Psychiatry Res
; 281: 112560, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31521843
5.
Medication adherence in patients with psychotic disorders: an observational survey involving patients before they switch to long-acting injectable risperidone.
Patient Prefer Adherence
; 9: 1333-41, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26396505